Saturday, October 5, 2024
HomeIndustries

Industries

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

Pfizer Inc. (NYSE: PFE) and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of...

Insperity and UnitedHealthcare Extend Relationship through 2026

Insperity, Inc., a leading provider of human resources and business performance solutions for America’s best businesses, announced an extension of its 20-year relationship for...

Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced...

Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis

Alentis Therapeutics, AG announced it has dosed the first cohort of healthy participants in a first-in-human Phase 1 clinical trial of ALE.F02, a monoclonal...

Onera Health Launches the Onera Biomedical-Lab-on-Chip™ at CES 2022

Onera Health announced Improved Pharma Contributes to Paper Advancing the Study of Sameness of Amorphous Materialsthe introduction of its first Onera Biomedical-Lab-on-Chip™. The biomedical...
0FansLike
0FollowersFollow
spot_img

Hot Topics